Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Andrew Gregory Health editor

Nice approves new migraine drug for NHS use in England and Wales

Migraines affect around one in five women and one in 15 men in the UK
Migraines affect around one in five women and one in 15 men in the UK. Photograph: PixelsEffect/Getty Images

Thousands of people in England and Wales who suffer from migraines could benefit from a drug that has been approved on the NHS.

The National Institute for Health and Care Excellence (Nice), the drugs regulator, said it was recommending eptinezumab for preventing migraine in about 164,000 adults where at least three previous preventive treatments had failed.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.